![TEVA's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile TEVA's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile](https://image4.owler.com/ceo/Michel_Vounatsos_owler_20210618_024449_original.jpg)
TEVA's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile
![DGAP-News: Formycon AG: Britische Arzneimittelbehörde MHRA erteilt Marktzulassung für FYB201, Formycon's Biosimilar für Lucentis1, das von Teva unter dem Namen ONGAVIA vermarktet werden wird DGAP-News: Formycon AG: Britische Arzneimittelbehörde MHRA erteilt Marktzulassung für FYB201, Formycon's Biosimilar für Lucentis1, das von Teva unter dem Namen ONGAVIA vermarktet werden wird](https://www.finanznachrichten.de/chart-formycon-ag-aktie-intraday-xetra.png)
DGAP-News: Formycon AG: Britische Arzneimittelbehörde MHRA erteilt Marktzulassung für FYB201, Formycon's Biosimilar für Lucentis1, das von Teva unter dem Namen ONGAVIA vermarktet werden wird
![Wettbewerberstudie zu den Hauptakteuren des Märkte für Isosorbidmononitrat 2022-2030 Teva, Merck, Nesher Pharmaceuticals, Taj Pharmaceutical, AMRI – GBS News – Anleger Trends Wettbewerberstudie zu den Hauptakteuren des Märkte für Isosorbidmononitrat 2022-2030 Teva, Merck, Nesher Pharmaceuticals, Taj Pharmaceutical, AMRI – GBS News – Anleger Trends](https://i0.wp.com/anleger-trends.de/wp-content/uploads/2022/04/wp-header-logo-2277.png?fit=780%2C466&ssl=1)
Wettbewerberstudie zu den Hauptakteuren des Märkte für Isosorbidmononitrat 2022-2030 Teva, Merck, Nesher Pharmaceuticals, Taj Pharmaceutical, AMRI – GBS News – Anleger Trends
![Tevano Systems Holdings Inc.: Tevano Wholly-Owned Subsidiary illuria Security, Inc. Announces the Availability of Its Open Source Tool manush Tevano Systems Holdings Inc.: Tevano Wholly-Owned Subsidiary illuria Security, Inc. Announces the Availability of Its Open Source Tool manush](https://www.finanznachrichten.de/chart-tevano-systems-holdings-inc-aktie-intraday-tradegate.png)
Tevano Systems Holdings Inc.: Tevano Wholly-Owned Subsidiary illuria Security, Inc. Announces the Availability of Its Open Source Tool manush
![MedinCell's partner Teva provides additional information regarding the New Drug Application for mdc-IRM MedinCell's partner Teva provides additional information regarding the New Drug Application for mdc-IRM](https://www.finanznachrichten.de/chart-medincell-sa-aktie-intraday-frankfurt.png)
MedinCell's partner Teva provides additional information regarding the New Drug Application for mdc-IRM
![TEVA's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile TEVA's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile](https://image4.owler.com/logo/amwell_owler_20211008_223058_original.png)